Sljedeći

Auto Play

ER+/HER2+ Metastatic Breast Cancer

2 Pogledi • 07/03/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play